Rounding up top reads from around the web, including articles shared by fellow investors in the
Financial Horse Facebook Group.
The first cohort of local volunteers has been dosed with a coronavirus vaccine jointly developed by Duke-NUS Medical School and United States pharmaceutical company Arcturus Therapeutics. Arcturus said in a statement on Tuesday (Aug 11) that this first phase of the trial involved volunteers aged between 21 and 55, who were injected with a single shot of the vaccine. Lunar-Cov19 contains genetic material called mRNA, which encodes part of the virus. Injected into a person, it causes the body’s cells to begin manufacturing a protein similar to that of the virus, allowing the body to recognise and learn to fight it.
Although the Inter-Agency Taskforce has completed...